Peptiomax™passes INCI registration and is officially launched
2018-07-04
Peptiomax™Peptiomax™passes INCI registration and is officially launched.
In December, 2006, Ginko International Group, Formosa Optical Technology Co. and American corp. raised fund together to set up this company. It recruited tens of masters and doctors in the field of microbiology, medical engineering, pharmacy, food engineering and China organic agriculture and aquaculture to develop and research high-end cosmetic formula, latest cosmetic formula, medical equipment and health food.
Meeting the consumer needs is company’s expectation. Horien keeps insisting on the concept of providing natural, effective and unharmful products for consumers. To continue enhancing the quality, Horien invested thousands of million to establish the most modern development and research centers in Taichung, Taiwan, Southeast University in Nanking, China, Qiqihar in Northeast.
So far, the collagen manufactured in the advanced clean room and leading lab, situated on 38 Rd. Taichung Industrial District is supplied to the dental instruments and exported to Western countries as the cosmetic material and basic material for cell culture. The repairing skin material, Gen-Nusis® and PeptioMax®, anti wrinkle material and Lifking, the growth factor of hair follicles, passed by clinical trial conducted by teaching hospital are exported to Europe and Asia countries.
Composed of 17 amino acids（INCI named Oligopeptide-35）, it is similar to certain growth factor structure in human body.
Semi growth factor can stimulate fibroblast to proliferate and secrete collagen, hyaluronic acid, ploysaccharide and intercellular substance.
The exclusive and special amino acids sequence designs active factor to stimulate fibroblast growth. Its small molecular weight in linear structure easily penetrates skin.
By means of stimulating the growth of fibroblast can get rid of the lines due to aging.
Specially strengthen the sequence design to reinforce the short peptide sequence which is deficient in activating fibroblast and improve micropeptide unsteady activity feature in the current market.
In December, 2006, Ginko International Group, Formosa Optical Technology Co. and American corp. raised fund together to set up this company. It recruited tens of masters and doctors in the field of microbiology, medical engineering, pharmacy, food engineering and China organic agriculture and aquaculture to develop and research high-end cosmetic formula, latest cosmetic formula, medical equipment and health food.
Meeting the consumer needs is company’s expectation. Horien keeps insisting on the concept of providing natural, effective and unharmful products for consumers. To continue enhancing the quality, Horien invested thousands of million to establish the most modern development and research centers in Taichung, Taiwan, Southeast University in Nanking, China, Qiqihar in Northeast.
So far, the collagen manufactured in the advanced clean room and leading lab, situated on 38 Rd. Taichung Industrial District is supplied to the dental instruments and exported to Western countries as the cosmetic material and basic material for cell culture. The repairing skin material, Gen-Nusis® and PeptioMax®, anti wrinkle material and Lifking, the growth factor of hair follicles, passed by clinical trial conducted by teaching hospital are exported to Europe and Asia countries.
Composed of 17 amino acids（INCI named Oligopeptide-35）, it is similar to certain growth factor structure in human body.
Semi growth factor can stimulate fibroblast to proliferate and secrete collagen, hyaluronic acid, ploysaccharide and intercellular substance.
The exclusive and special amino acids sequence designs active factor to stimulate fibroblast growth. Its small molecular weight in linear structure easily penetrates skin.
By means of stimulating the growth of fibroblast can get rid of the lines due to aging.
Specially strengthen the sequence design to reinforce the short peptide sequence which is deficient in activating fibroblast and improve micropeptide unsteady activity feature in the current market.